Gene Signature for Liver Cancer Recurrence Found
WEDNESDAY, Oct. 15 — Researchers have identified a new genetic signature that may predict whether a liver tumor is likely to recur, according to a new study.
Unlike other such signatures that have been identified for other cancers, this one has something of a flourish: It is hidden not within the tumor itself, but in the normal cells that surround it — and which, by inference, remain in the body following surgery.
The findings potentially open the door to new surveillance, treatment, and intervention strategies for liver cancer patients, both after surgery and possibly before the primary cancer ever arises, experts said.